Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

AZ advances immuno-oncology ambitions

Buys imaging company and signs PD-1 collaborations with Pharmacyclics and J&J

Bristol-Myers Squibb (BMS) building

BMS takes option to buy fibrosis firm Galecto

The Swedish biotech has a pulmonary fibrosis candidate in early-stage testing

- PMLiVE

Astellas earmarks up to $1.2bn for protein folding research

Teams up with US company to investigate diseases caused by protein defects

- PMLiVE

Former NICE chair Sir Michael Rawlins to lead MHRA

He will take up his new role at the UK's medicines and devices regulator in December

- PMLiVE

Horizon Discovery appoints executive director

David Smoller is chief business officer at the genomics firm

- PMLiVE

Publicis Groupe to acquire Sapient for $3.7bn

Merger comes just months after Publicis’ failed acquisition of Omnicom

- PMLiVE

NICE backs GSK drug for leukaemia

Arzerra on course for NHS use in blood cancer

- PMLiVE

Novo Nordisk’s Klaus Henning Jensen on trends in medical affairs

PMLiVE speaks to the head of clinical, medical and regulatory for Novo in the UK and Ireland

09 Thinking Healthcare Wearables Strategy

Function over fashion

Havas Lynx

Biogen Idec building

EMA starts review of Biogen Idec’s haemophilia A therapy

Elocta already on the market in the US, Canada and Australia

- PMLiVE

AbbVie is not looking at another big acquisition, says CEO

Unlikely to consider another deal on the scale of failed Shire merger

Bayer symbol

Bayer completes takeover of Chinese OTC company

Expands consumer health presence with Dihon purchase

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links